3/A

PRIMARY DOCUMENT

Company: ELITE PHARMACEUTICALS INC /NV/
Filed: March 18, 2014
Period of Report: March 18, 2014
Accession Number: 0001213711-14-000001

View Document ↗ View on SEC.gov ↗